Best Supplements for Mood UK: Lifting Low Mood Naturally

By Will  •  Posted on August 2, 2026  •  15 minutes  • 3110 words

About the author...

Will founded Supermushrooms after digging into the research behind mushroom and nootropic supplements. Every pick is checked against clinical dosing, extract standardisation, and real buyer reviews, and each star rating starts from a product's real Amazon score before being adjusted for formulation quality. Read more about how ratings are calculated.

Saffron has the strongest evidence of any natural supplement for low mood, with trial results comparable to prescription antidepressants in some studies, followed by 5-HTP, NAC, and Ashwagandha for related angles on serotonin, oxidative stress, and cortisol. None of these are a substitute for treating a diagnosed clinical depression.

Low mood is one of the most common reasons UK adults look for a natural intervention before, alongside, or instead of a trip to the GP. ONS wellbeing data from April 2025 put the proportion of adults reporting moderate to severe depressive symptoms at 18%, rising to roughly a quarter of those aged 16 to 29. Most of this sits below the threshold for a clinical diagnosis: flat, low, unmotivated, tired of everything, but not necessarily meeting the criteria for major depressive disorder. It's this subclinical territory, sometimes called "low mood" in the research literature, where nutritional and herbal supplements have the most defensible evidence base.

That distinction matters. None of the six supplements covered in this guide are a substitute for treating diagnosed depression, and none should be used as a reason to delay speaking to a GP if symptoms are persistent or severe. What the clinical trial evidence does support, in varying degrees of strength, is a role for specific nutrients and botanicals in supporting mood regulation through mechanisms that are reasonably well understood: serotonin precursor supply, oxidative stress reduction, cortisol modulation, and correcting outright nutrient deficiencies that are common in UK diets.

This guide works through the six supplements with the strongest case for mood support, explains the mechanism behind each one, and links to our dedicated review pages so you can compare specific UK products. It closes with guidance on combining them sensibly and a FAQ section addressing the questions we get asked most often about safety and realistic expectations.

How Mood Supplements Work: Three Distinct Pathways

Before looking at individual supplements, it helps to understand that they aren't all doing the same job. Three broad mechanisms come up repeatedly in the mood research:

Neurotransmitter precursor supply. Serotonin can't be taken as a supplement directly (it doesn't cross the blood-brain barrier), so supplements instead provide the raw materials the brain converts into serotonin itself. 5-HTP is the most direct example, sitting one enzymatic step away from serotonin in the biosynthetic pathway.

Stress hormone and HPA axis modulation. Chronically elevated cortisol is linked to low mood, disrupted sleep and impaired hippocampal function. Adaptogens such as ashwagandha and rhodiola rosea work primarily by blunting the stress response and normalising cortisol output, rather than acting directly on mood neurotransmitters.

Correcting deficiency and oxidative load. Magnesium deficiency is genuinely common in UK diets heavy in processed food and alcohol, and low magnesium status correlates with worse mood outcomes in observational data. NAC works on a related but distinct axis, replenishing glutathione and reducing the oxidative stress and inflammation increasingly implicated in mood disorders.

Saffron is the outlier here: it appears to act on several of these pathways simultaneously, which may explain why its trial data looks more like an antidepressant's than a typical supplement's.

Saffron — Antidepressant-Comparable Evidence

Saffron, the dried stigma of Crocus sativus, has one of the more unusual evidence bases in the supplement world. Multiple randomised, double-blind, placebo-controlled trials, several using the standardised extract branded Affron, have tested saffron directly against SSRIs like fluoxetine and imipramine in people with mild to moderate depression, rather than only against placebo. A number of these head-to-head trials found no significant difference in symptom reduction between saffron and the pharmaceutical comparator, which is a much higher evidentiary bar than most supplements ever attempt to clear.

More recent trials have moved the research into subclinical territory that maps closely onto this guide's subject: a 2025 randomised, double-blind, placebo-controlled study specifically recruited adults experiencing low mood rather than diagnosed depression and found meaningful improvements in mood and general wellbeing scores over the study period. This matters because it separates saffron's effect from the "regression to the mean" pattern you'd expect in a severely depressed population, where most interventions (including placebo) tend to show improvement.

The proposed mechanism involves crocin and safranal, saffron's key bioactive compounds, modulating serotonin reuptake and exerting anti-inflammatory and antioxidant effects in the brain. Doses in the positive trials cluster around 28 to 30mg of standardised extract daily. When buying, look for a named, clinically studied extract (Affron is the most heavily researched) with a stated crocin or safranal content, rather than generic "saffron powder" with no standardisation.

5-HTP — The Serotonin Precursor Route

5-hydroxytryptophan is the direct metabolic intermediate between the amino acid tryptophan and serotonin. Unlike tryptophan, which competes with other amino acids for transport across the blood-brain barrier, 5-HTP crosses more efficiently and is converted to serotonin by a single enzyme (aromatic L-amino acid decarboxylase). This gives it a more direct route to raising brain serotonin availability than dietary tryptophan alone.

The clinical picture is promising but not settled. A widely cited review found that 5-HTP supplementation reliably increases plasma serotonin and its metabolites, confirming the mechanism works as intended, though the review's authors were candid that many of the depression trials behind this finding are older, smaller, and methodologically weaker than modern standards would require. A more recent 12-week randomised controlled trial in older adults in Singapore found that 100mg of daily 5-HTP modestly improved cognitive scores and reduced depressive symptoms compared with no supplementation, one of the few recent trials to test 5-HTP specifically for mood in a well-characterised population.

The most important buying and safety consideration with 5-HTP is drug interaction risk. Because it raises serotonin directly, it should not be combined with SSRIs, SNRIs, MAOIs or St John's Wort without medical supervision: the combination can precipitate serotonin syndrome, a rare but serious condition. Anyone currently prescribed an antidepressant should discuss 5-HTP with their GP or pharmacist before starting it, not after. Typical supplemental doses range from 50 to 100mg daily, usually taken in the evening since 5-HTP can be mildly sedating.

NAC — The Oxidative Stress and Glutathione Angle

N-acetylcysteine supplies cysteine, the rate-limiting amino acid in the body's synthesis of glutathione, the brain's primary antioxidant. The rationale for using NAC in mood support comes from a growing body of research linking oxidative stress and low-grade neuroinflammation to depressive symptoms, a mechanism quite distinct from the serotonin-focused theories behind saffron and 5-HTP.

The clinical trial evidence is genuinely mixed, and it's worth being direct about that rather than overselling it. A large 12-week randomised, placebo-controlled trial of adjunctive NAC in major depressive disorder found no significant difference from placebo on the primary depression rating scale, a result that tempers some of the enthusiasm generated by earlier, smaller open-label studies in bipolar depression. Where NAC has shown more consistent signal is in populations with a clearer oxidative stress component: a trial in multiple sclerosis patients found NAC supplementation reduced markers of lipid peroxidation alongside improvements in anxiety symptoms, supporting the underlying mechanism even where broader depression trial data has been inconsistent.

The practical takeaway is that NAC is better framed as a plausible adjunct for people with an oxidative stress or inflammatory component to their low mood (heavy alcohol use, smoking, chronic illness) than as a frontline mood supplement on its own. It's also well tolerated and has a long safety record from its use in respiratory medicine, which makes it a reasonably low-risk addition to a broader stack. Typical doses in the trials range from 1 to 3g daily, usually split across two doses.

Ashwagandha — Lowering the Cortisol Load

Ashwagandha's mood-support case rests less on direct serotonergic action and more on its well-documented ability to reduce circulating cortisol. Chronically elevated cortisol from ongoing psychological stress is associated with low mood, disrupted sleep, and impaired motivation, so a supplement that reliably brings cortisol down addresses one of the upstream drivers rather than the mood symptom itself.

A 2023 randomised, double-blind, placebo-controlled trial of a standardised ashwagandha root extract found a significantly greater reduction in morning salivary cortisol in the treatment group compared with placebo, alongside an increase in urinary serotonin, a secondary finding that hints at a more direct neurotransmitter effect than earlier research had established. Broader systematic reviews pooling multiple ashwagandha trials consistently report significant reductions in perceived stress and anxiety scores alongside the cortisol effect, which is a more robust evidence base than most single-ingredient adaptogens can claim.

For mood specifically, ashwagandha is best suited to people whose low mood tracks closely with a stressful period: work pressure, poor sleep, general overwhelm, rather than a mood disturbance that appears unconnected to circumstances. Effects typically build over four to eight weeks rather than appearing immediately. Look for standardised root extracts (KSM-66 and Sensoril are the two most studied trademarked extracts) at doses of 300 to 600mg daily, and check whether a product uses root-only extract or a root-and-leaf combination, since withanolide content and side-effect profile differ between the two.

Rhodiola Rosea — Stress-Related Low Mood and Fatigue

Rhodiola occupies a similar adaptogen category to ashwagandha but with a distinct mechanism and a notably faster onset, often within one to two weeks rather than a month or more. Its standardised extract (usually labelled SHR-5) appears to work through mild inhibition of monoamine oxidase enzymes, which slows the breakdown of serotonin and dopamine, combined with the same HPA axis and cortisol-modulating effects seen with other adaptogens.

The most instructive trial for this guide's purposes is a 12-week randomised, placebo-controlled comparison of Rhodiola rosea extract against sertraline (a commonly prescribed SSRI) in adults with major depressive disorder. Both active treatments produced modest reductions in depression rating scale scores relative to placebo, without a statistically significant difference between rhodiola and sertraline, and rhodiola produced markedly fewer side effects and a lower discontinuation rate. The authors were careful to frame this as rhodiola having a less potent but considerably more tolerable effect profile than the pharmaceutical, not as evidence that it can replace prescribed antidepressants for diagnosed depression.

Rhodiola is a sensible choice for low mood that presents mainly as fatigue, burnout or reduced stress tolerance, particularly where a faster-acting adaptogen is preferred over ashwagandha's slower build. Standard doses run 300 to 500mg daily of extract standardised to at least 3% rosavins and 1% salidroside, and because of its mild stimulating quality it's generally better taken earlier in the day rather than before bed.

Magnesium Glycinate — Closing a Common Deficiency Gap

Magnesium's link to mood is less about a novel pharmacological effect and more about correcting a genuinely widespread shortfall. UK dietary surveys consistently show a meaningful proportion of adults falling short of the NHS reference intake of 300mg a day for men and 270mg for women, and factors that are common in modern life, alcohol intake, high caffeine consumption, chronic stress, and diets low in leafy greens and legumes, all increase magnesium losses further.

Magnesium is a cofactor in several hundred enzymatic reactions, including ones that regulate NMDA receptor activity and GABA signalling, both of which are implicated in mood regulation. A 2023 systematic review and meta-analysis pooling seven randomised clinical trials found a significant reduction in depression scores with magnesium supplementation compared with placebo, though the authors were appropriately cautious given the modest total sample size (325 participants across all trials combined) and called for larger confirmatory studies before magnesium could be considered a mainstream depression intervention.

Where magnesium earns its place in this guide is as a low-risk, evidence-supported option for people whose low mood coexists with other classic deficiency signs: poor sleep, muscle tension, irritability, or fatigue. The glycinate form is generally preferred over cheaper oxide forms because it's better absorbed and doesn't carry the same laxative effect at effective doses. Typical supplemental doses sit around 200 to 400mg of elemental magnesium daily, usually taken in the evening given its mild calming effect.

How to Combine These Supplements Safely

None of these six need to be taken together, and stacking all of them at once makes it harder to identify what's actually helping. A more sensible approach is to pick one supplement that matches your specific pattern of low mood, give it six to eight weeks at a consistent dose, and only add a second if the first shows a partial effect.

That said, some combinations are more logical than others. Magnesium glycinate pairs well with either adaptogen, since it addresses a different mechanism (deficiency correction rather than cortisol modulation) and is typically taken in the evening alongside rhodiola or ashwagandha without any known interaction concern. Saffron and magnesium is a reasonable low-risk starting stack for general low mood without a strong stress or fatigue component.

The combination to actively avoid is doubling up on serotonergic agents. 5-HTP should not be combined with saffron, St John's Wort, or any prescribed antidepressant without medical guidance, since several of these act on the same serotonin pathway and the risk isn't simply additive, it can compound in ways that are difficult to predict outside a clinical setting. NAC is generally the safest to combine with anything else on this list, though it's sensible to leave a couple of hours between NAC and any other supplement or medication, since its acidity can affect absorption of some things taken at the same time.

Anyone currently on prescribed medication for depression or anxiety, or with a diagnosed mental health condition, should treat this whole list as something to discuss with a GP or pharmacist before starting, rather than something to combine with existing treatment unilaterally.

When Low Mood Needs More Than a Supplement

The supplements in this guide are aimed at mild, subclinical low mood, the kind that shows up as reduced motivation, flatness, or a general sense of being run down, without meeting the threshold for a depression diagnosis. They are not a treatment for major depressive disorder, and none of the trial evidence above should be read as suggesting otherwise.

If low mood has lasted more than two weeks, is affecting work, relationships or basic functioning, or is accompanied by thoughts of self-harm, the right next step is a GP appointment, not a supplement order. NHS Talking Therapies allows self-referral in England without needing to see a GP first, and Samaritans (116 123) is available around the clock for anyone who needs to talk immediately. Supplements can sit alongside clinical treatment in some cases, but that should always be a conversation with the prescribing clinician, particularly given the antidepressant interaction risks noted above for 5-HTP and saffron.

FAQ

Can supplements actually treat depression, or only support mild low mood?

The strongest trial evidence, including for saffron, comes from studies in subclinical or mild-to-moderate populations rather than severe, treatment-resistant depression.¹ For diagnosed major depressive disorder, supplements should be discussed with a GP as a potential adjunct at most, never a replacement for clinical treatment.

Is it safe to take 5-HTP alongside an antidepressant?

No, not without medical supervision. 5-HTP raises serotonin through a direct precursor mechanism,² and combining it with SSRIs, SNRIs or MAOIs carries a risk of serotonin syndrome. A 12-week trial in older adults did find mood and cognitive benefits from 5-HTP taken alone,³ but anyone on prescribed antidepressant medication should speak to their GP before adding it.

Does NAC actually help with mood?

The evidence is mixed. A large randomised trial of adjunctive NAC in major depressive disorder found no significant benefit over placebo on the primary outcome measure,⁴ though NAC has shown more consistent effects in populations with a clearer oxidative stress component. It's reasonable as a low-risk addition rather than a frontline mood supplement.

Can ashwagandha lift low mood, or is it only for stress?

Ashwagandha's mood effects appear to work indirectly, through cortisol reduction, with one 2023 trial also noting an increase in urinary serotonin alongside the cortisol drop.⁵ It tends to suit low mood that tracks closely with a stressful period rather than mood disturbance with no obvious trigger.

Is Rhodiola rosea as effective as prescribed antidepressants?

A head-to-head trial against sertraline found comparable, modest reductions in depression scores, with rhodiola causing significantly fewer side effects and a lower dropout rate.⁶ That doesn't mean rhodiola matches sertraline's effect size for moderate-to-severe depression, only that it performed similarly in this particular mild-to-moderate trial population while being better tolerated.

Could my low mood be linked to a magnesium deficiency?

It's possible. A 2023 meta-analysis of seven randomised trials found magnesium supplementation significantly reduced depression scores compared with placebo,⁷ though the total trial pool remains small. Magnesium is worth considering particularly if low mood coincides with poor sleep, muscle tension or irritability.

Conclusion

There's no single best supplement for mood, because low mood itself isn't one thing. Saffron has the most consistent, antidepressant-comparable trial data and is a reasonable starting point for general low mood without a clear trigger. 5-HTP offers a more direct serotonin route but carries real interaction risks that rule it out for anyone on prescribed antidepressants. NAC is better reserved for cases with an oxidative stress component rather than used as a first-line option. Ashwagandha and rhodiola both work through stress hormone modulation and suit low mood that tracks with a stressful period, with rhodiola acting faster and ashwagandha offering a somewhat broader evidence base. Magnesium is the lowest-risk option of the six and worth ruling in or out early, given how common a shortfall is in UK diets.

Whichever you choose, give it a proper six-to-eight-week trial at a consistent dose before judging whether it's working, and treat persistent or worsening symptoms as a reason to see a GP rather than to keep experimenting with supplements alone.